Research

Artificial kidney project led by Roy chosen for accelerated FDA program

Mon Apr 9, 2012

Shuvo Roy, PhD with a model of the device

The effort led by UCSF bioengineer Shuvo Roy, PhD, to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the U.S. Food and Drug Administration (FDA).

New NIH funding awarded to UCSF School of Pharmacy postdoctoral fellows in 2011

Wed Apr 4, 2012

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included two on-going projects by postdoctoral fellows:

Shoichet is the new director of the QB3 at UCSF

Tue Apr 3, 2012

Brian Shoichet, PhD

Computational chemist Brian Shoichet, PhD, a faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, is the new director of the California Institute for Quantitative Biosciences

The HIV pharmacist: helping patients pick and stick with lifesaving drugs

Wed Feb 22, 2012

Jennifer Cocohoba, PharmD

How do you convince patients who feel fine to take medicines that can have major side effects?

How can you help them stay on their lifesaving daily medications for years to come despite the obstacle course of everyday life?

Study finds including unpublished FDA data alters drug effectiveness outcomes

Fri Jan 20, 2012

Lisa Bero, PhD

Every year U.S. drug regulators approve dozens of new medicines as “safe and effective,” but just how effective are they? How well do they alleviate specific aspects of illness, whether light sensitivity from migraine headaches or itching from eczema?

Partners in D program wins AACP Award for Student Community Service

Mon Jan 9, 2012

Partners in D student pharmacists counsel seniors.

Partners in D, the innovative program in which UCSF student pharmacists help both underserved seniors and fellow health professionals maximize the complex Medicare Part D drug benefit, has won a national award for community service.

Soller defines the roadmap for Rx-to-OTC switches

Tue Nov 29, 2011

William Soller, PhD

If you are a pharmaceutical company seeking to switch your prescription medication to one sold directly to consumers—as an over-the-counter or OTC drug—William Soller, PhD, has your road map.

Computer models to predict drug clearance by liver cells show promise

Tue Nov 22, 2011

A schematic diagram of the mechanisms built into each cell in the in silico hepatocyte cultures. Checkmarks indicate events affected by the physical and chemical properties of a specific virtual drug object. For example, depending on such properties a given drug bound to an enzyme can have a different probability of being metabolized or released. (Source: Drug Metab Dispos. 2011 Oct;39(10):p. 1910-20)

A holy grail of drug discovery is to answer key questions about potential new drugs less by experiments in petri dishes and lab animals and more by faster, cheaper engineering efforts using predictive computer models.

Consortium inventing medical devices for children gets new funding

Thu Nov 10, 2011

Shuvo Roy, PhD

A two-year-old, cross-disciplinary effort to invent new medical devices for children, co-founded by bioengineer Shuvo Roy, PhD, has received a two-year $1 million grant from the U.S. Food and Drug Administration (FDA) to expand its work.

Bero heads new WHO center studying, promoting global access to vital drugs

Wed Nov 9, 2011

Cindy Chew